Visual Outcomes in Giant Cell Arteritis in Patients with Polymyalgia Rheumatica on Prior Corticosteroids

Update Item Information
Identifier 20150224_nanos_posters_245
Title Visual Outcomes in Giant Cell Arteritis in Patients with Polymyalgia Rheumatica on Prior Corticosteroids
Creator Nailyn Rasool; Philip M. Skidd; Joseph F. Rizzo
Affiliation (NR) (JFR) Neuro-Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA; (PMS) Neuro-Ophthalmology, Fletcher Allen, Vermont College of Medicine, Burlington, VT
Subject Vascular Disorders; Optic Neuropathy; Giant Cell Arteritis; Arteritic Ischemic Optic Neuropathy; Polymyalgia Rheumatica
Description Blindness caused by giant cell arteritis (GCA) is usually severe. Some patients with GCA have an earlier diagnosis of polymyalgia rheumatica (PMR), in which case they receive relatively low dose corticosteroids to alleviate discomfort.1 We hypothesized that GCA patients who were receiving corticosteroids prior to visual loss would have less severe visual loss than patients who had not received corticosteroids in advance.
Date 2015-02-24
Language eng
Format application/pdf
Type Text
Source 2015 North American Neuro-Ophthalmology Society Annual Meeting
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
ARK ark:/87278/s6xd47k2
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 184960
Reference URL https://collections.lib.utah.edu/ark:/87278/s6xd47k2
Back to Search Results